Skye Bioscience, Inc. — insider transactions
9 transactions on record · CIK 1516551
Aggregates
computed from the filings belowPurchases, 12m
0
count of open-market buys
Sales, 12m
9
count of open-market sales
Buy / sell ratio, 12m
0.00
purchases per sale
Distinct insiders, 12m
1
Bought, 3m
$0
Sold, 3m
$140.3K
Median disclosure lag
1.0 d
trade date to filing date
Largest single trade, 24m
$96.2K
2026-08-18
Director share, 12m
0.0%
of transactions where role is stated
Current run
9 sells
consecutive same-direction transactions
Net 3m flow
-$140.3K
purchases minus sales
Total on record
9
Transactions
9 most recent shown| Disclosed | Traded | Lag, d | Insider | Role | Transaction | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-20 | 2026-08-18 | 2 | ROCKLAGE SCOTT M | 10% Owner | Open market sale | 45,090 | $0.38 | $17.1K | filing |
| 2026-08-20 | 2026-08-18 | 2 | ROCKLAGE SCOTT M | 10% Owner | Open market sale | 1,830 | $0.38 | $695.4 | filing |
| 2026-08-20 | 2026-08-18 | 2 | ROCKLAGE SCOTT M | 10% Owner | Open market sale | 253,080 | $0.38 | $96.2K | filing |
| 2026-08-20 | 2026-08-19 | 1 | ROCKLAGE SCOTT M | 10% Owner | Open market sale | 10,255 | $0.35 | $3.6K | filing |
| 2026-08-20 | 2026-08-19 | 1 | ROCKLAGE SCOTT M | 10% Owner | Open market sale | 409 | $0.35 | $143.1 | filing |
| 2026-08-20 | 2026-08-19 | 1 | ROCKLAGE SCOTT M | 10% Owner | Open market sale | 57,476 | $0.35 | $20.1K | filing |
| 2026-08-20 | 2026-08-20 | 0 | ROCKLAGE SCOTT M | 10% Owner | Open market sale | 1,159 | $0.32 | $370.9 | filing |
| 2026-08-20 | 2026-08-20 | 0 | ROCKLAGE SCOTT M | 10% Owner | Open market sale | 46 | $0.32 | $14.7 | filing |
| 2026-08-20 | 2026-08-20 | 0 | ROCKLAGE SCOTT M | 10% Owner | Open market sale | 6,495 | $0.32 | $2.1K | filing |